Trials / Available
AvailableNCT07502716
Compassionate Use of Ubamatamab
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Regeneron Pharmaceuticals · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Provide Compassionate Use of Ubamatamab
Detailed description
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ubamatamab |
Timeline
- First posted
- 2026-03-31
- Last updated
- 2026-03-31
Source: ClinicalTrials.gov record NCT07502716. Inclusion in this directory is not an endorsement.